Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease

Clinical trial NCT05576415 · COMPLETED

Trial details

NCT number: NCT05576415
Sponsor: Corxel Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dry Eye Disease

Start date: 2022-12-07
Primary completion: 2023-04-27
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.